These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7519033)

  • 1. Localization of transforming growth factor-alpha RNA and protein in the skin of psoriatic patients receiving therapy.
    Watts P; Stables GS; Akhurst RJ; Mackie RM
    Br J Dermatol; 1994 Jul; 131(1):64-71. PubMed ID: 7519033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of transforming growth factor-alpha (TGF-alpha) and EGF receptor in transitional area of psoriatic epidermis.
    Higashiyama M; Hashimoto K; Matsumoto K; Yoshikawa K
    J Dermatol Sci; 1994 Feb; 7(1):45-53. PubMed ID: 7514888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization of elevated transforming growth factor-alpha in psoriatic epidermis.
    Turbitt ML; Akhurst RJ; White SI; MacKie RM
    J Invest Dermatol; 1990 Aug; 95(2):229-32. PubMed ID: 2380581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of transforming growth factor alpha in psoriatic epidermis.
    Elder JT; Fisher GJ; Lindquist PB; Bennett GL; Pittelkow MR; Coffey RJ; Ellingsworth L; Derynck R; Voorhees JJ
    Science; 1989 Feb; 243(4892):811-4. PubMed ID: 2916128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABC of dermatology. Treatment of psoriasis.
    Going SM
    Br Med J (Clin Res Ed); 1987 Oct; 295(6604):984-6. PubMed ID: 3119131
    [No Abstract]   [Full Text] [Related]  

  • 6. Alteration of the expression of Bcl-2, Bcl-x, Bax, Fas, and Fas ligand in the involved skin of psoriasis vulgaris following topical anthralin therapy.
    Yamamoto T; Nishioka K
    Skin Pharmacol Appl Skin Physiol; 2003; 16(1):50-8. PubMed ID: 12566829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Keratin gene expression during the resolution of psoriatic plaques: effect of dithranol, PUVA, etretinate and hydroxyurea regimens.
    Holland DB; Wood EJ; Cunliffe WJ; Turner DM
    Br J Dermatol; 1989 Jan; 120(1):9-19. PubMed ID: 2484124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of transforming growth factor-alpha (TGF-alpha) in cholesteatoma.
    Shiwa M; Kojima H; Moriyama H
    J Laryngol Otol; 1998 Aug; 112(8):750-4. PubMed ID: 9850316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential localization of TGF-beta-precursor isotypes in psoriatic human skin.
    Wataya-Kaneda M; Hashimoto K; Kato M; Miyazono K; Yoshikawa K
    J Dermatol Sci; 1996 Mar; 11(3):183-8. PubMed ID: 8785168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-beta 1 localization in normal and psoriatic epidermal keratinocytes in situ.
    Kane CJ; Knapp AM; Mansbridge JN; Hanawalt PC
    J Cell Physiol; 1990 Jul; 144(1):144-50. PubMed ID: 1694857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of psoriasis. Results achieved by the Johannesburg Hospital Psoriasis Clinic.
    Sher MA; Sher B; Berro V
    S Afr Med J; 1986 Jan; 69(1):23-6. PubMed ID: 3941938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased production of transforming growth factor-alpha in psoriatic epidermis.
    Higashiyama M; Matsumoto K; Hashimoto K; Yoshikawa K
    J Dermatol; 1991 Feb; 18(2):117-9. PubMed ID: 2071743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organ culture of psoriatic skin: effect of TGF-alpha and TGF-beta on epidermal structure in vitro.
    Kondo S; Hozumi Y; Maejima H; Aso K
    Arch Dermatol Res; 1992; 284(3):150-3. PubMed ID: 1503499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal expression of interleukin-6 and tumour necrosis factor-alpha in normal and immunoinflammatory skin states in humans.
    Oxholm A
    APMIS Suppl; 1992; 24():1-32. PubMed ID: 1567657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth factor and proto-oncogene expression in psoriasis.
    Elder LT; Klein SB; Tavakkol A; Fisher GJ; Nickoloff BJ; Voorhees JJ
    J Invest Dermatol; 1990 Nov; 95(5 Suppl):7S-9S. PubMed ID: 16788617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anthralin-corticosteroid combination therapy in the treatment of chronic plaque psoriasis.
    Monk BE; Hehir ME; Clement MI; Pembroke AC; du Vivier A
    Arch Dermatol; 1988 Apr; 124(4):548-50. PubMed ID: 3355198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Psoriasis and day hospital. Clinical and therapeutic considerations concerning 104 cases].
    Cattaneo M; de Thierry G; Betti R; Lodi A; Marmini A
    Minerva Med; 1986 Jun; 77(26):1271-5. PubMed ID: 3725152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of coal tar on cignolin erythema--1 hour treatment of psoriasis with high-dose cignolin with and without tar].
    Schauder S; Mahrle G
    Z Hautkr; 1985 Jun; 60(11):875-83. PubMed ID: 3160177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative studies on the reactions of psoriatic epidermis to treatment.
    McMinn RM; Woods MS; Fry L
    Acta Derm Venereol; 1980; 60(6):491-4. PubMed ID: 6162333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The epidermal Langerhans' cell population in psoriasis during topical coal tar therapy.
    Puttick LM; Johnson GD; Walker L
    Acta Derm Venereol; 1986; 66(4):343-6. PubMed ID: 2430408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.